Carrie L. Dul

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping

Pat W. Whitworth, Peter D. Beitsch, Angela Mislowsky et al. · Annals of Surgical Oncology · 2016 · 82 citations · Full text

Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

Peter D. Beitsch, Pat W. Whitworth, Paul L. Baron et al. · Annals of Surgical Oncology · 2017 · 43 citations

Her2+ Breast Cancer, Breast Oncology, Oncology +6

Effect of Pregnancy on the Pharmacokinetics of Paclitaxel: A Case Report

Jennifer L. Lycette, Carrie L. Dul, Myrna Y. Munar et al. · Clinical Breast Cancer · 2006 · 39 citations

Medicine, Reproductive Health, Gynecology +8

Radiation and depression associated with complications of tissue expander reconstruction

Paul J. Chuba, William A. Stefani, Carrie L. Dul et al. · Breast Cancer Research and Treatment · 2017 · 21 citations

Tissue Expander Reconstruction, Radiation Therapy, Reconstructive Surgery +5

Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature

Pat W. Whitworth, Peter D. Beitsch, James Pellicane et al. · JCO Precision Oncology · 2022 · 18 citations · Full text